More tools:Markets·Screener·Research·Chat

MiMedx Group, Inc (MDXG) Financial Statements

MiMedx Group, Inc
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001STPW96
XNAS · usd
4.67▲ 0.10 (2.19%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close4.57
Day's Range4.43 – 4.73
52-Week Range3.03 – 7.97
Volume1.1M
Avg Volume1.3M
Share Statistics
Shares Outstanding
Employees808
ExchangeXNAS
Listed2007-08-22
Share count as of July 23, 2026
Loading Income Statement…
Key questions about MiMedx Group, Inc (MDXG)
What is MiMedx Group, Inc's Market Cap?
MiMedx Group, Inc's Market Cap is $680.7M, based on as-reported figures from SEC (XBRL) filings.
What is MiMedx Group, Inc's Enterprise Value?
MiMedx Group, Inc's Enterprise Value is $562.1M, based on as-reported figures from SEC (XBRL) filings.
What is MiMedx Group, Inc's Trailing P/E?
MiMedx Group, Inc's Trailing P/E is 109.1×, based on as-reported figures from SEC (XBRL) filings.
What is MiMedx Group, Inc's Price / Sales?
MiMedx Group, Inc's Price / Sales is 1.9×, based on as-reported figures from SEC (XBRL) filings.
What is MiMedx Group, Inc's EV / Revenue?
MiMedx Group, Inc's EV / Revenue is 1.6×, based on as-reported figures from SEC (XBRL) filings.
What is MiMedx Group, Inc's EV / EBITDA?
MiMedx Group, Inc's EV / EBITDA is 23.2×, based on as-reported figures from SEC (XBRL) filings.
What is MiMedx Group, Inc's Revenue (TTM)?
MiMedx Group, Inc's Revenue (TTM) is $355.2M, based on as-reported figures from SEC (XBRL) filings.
What is MiMedx Group, Inc's Net Income (TTM)?
MiMedx Group, Inc's Net Income (TTM) is $6.2M, based on as-reported figures from SEC (XBRL) filings.
What is MiMedx Group, Inc's EBITDA?
MiMedx Group, Inc's EBITDA is $23.6M, based on as-reported figures from SEC (XBRL) filings.
What is MiMedx Group, Inc's Diluted EPS (TTM)?
MiMedx Group, Inc's Diluted EPS (TTM) is 0.04, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net sales
YoY growth-34.7%-33.1%+27.1%+35.3%
Cost of sales
Gross profit
% of revenue69.0%70.6%83.9%83.5%
Operating expenses:
Selling, general and administrative
Research and development
Amortization of intangible assets
Operating income
% of revenue-28.7%-27.2%17.8%19.5%
Other expense, net
Interest income, net
Other expense, net
(Loss) income before income tax
Income tax benefit (provision)
Net (loss) income
% of revenue-23.1%-18.4%12.9%14.7%
Basic net (loss) income per common share (in dollars per share)—
Diluted net (loss) income per common share (in dollars per share)—